GlassScriptPhysician profile
Morgan Ashley Weinstein
NPI 1851927552
$10,129.17
in general payments reported to CMS, 2019-2025
49 companies · $2,582 in 2025
The $2,582 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,530 · 2023: $3,580 · 2024: $2,437 · 2025: $2,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,523 · Education: $76.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,522.79 |
| Education | $76.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,278.01 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,258.65 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Pfizer INC. | $611.07 | 2023-2025 | |
| Ucb, INC. | $544.13 | 2022-2025 | Zilbrysq, Nayzilam, Fintepla |
| Ge Healthcare | $483.07 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $440.92 | 2022-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $414.64 | 2022-2025 | Kisunla, Amyvid, Emgality |
| Mdd US Operations, LLC | $406.12 | 2022-2025 | Gocovri, Gocovri, Qelbree |
| Harmony Biosciences LLC | $326.38 | 2022-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $323.26 | 2023-2025 | Hyqvia, Trintellix |
| Emd Serono, INC. | $319.67 | 2023-2025 | Mavenclad |
| Otsuka America Pharmaceutical, INC. | $298.30 | 2023-2025 | Nuedexta, Rexulti |
| Novartis Pharmaceuticals Corporation | $278.47 | 2022-2025 | |
| Boston Scientific Corporation | $261.66 | 2023-2025 | Vercise |
| Jazz Pharmaceuticals INC. | $245.62 | 2023-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $229.87 | 2022-2024 | |
| Eisai INC. | $226.34 | 2022-2025 | |
| Argenx US, INC. | $215.65 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Celgene Corporation | $191.21 | 2023-2025 | Zeposia |
| Lundbeck LLC | $183.23 | 2022-2025 | Vyepti, Rexulti |
| Tanabe Pharma America, INC. | $136.41 | 2022-2025 | Radicava |
| Acadia Pharmaceuticals INC | $121.40 | 2022-2025 | Nuplazid |
| Supernus Pharmaceuticals, INC. | $121.23 | 2024 | Qelbree |
| Biogen, INC. | $105.66 | 2023-2025 | Vumerity, Tysabri, Skyclarys |
| Vanda Pharmaceuticals INC. | $74.73 | 2022-2023 | Hetlioz |
| Acorda Therapeutics, INC | $73.27 | 2022-2024 | Ampyra, Inbrija |
| Janssen Biotech, INC. | $71.74 | 2025 | |
| Avanir Pharmaceuticals, INC. | $65.35 | 2022 | |
| Csl Behring | $62.63 | 2024-2025 | Hizentra |
| Axsome Therapeutics, INC. | $62.36 | 2024-2025 | Symbravo, Sunosi |
| Neurelis, INC. | $59.79 | 2022 | |
| Genentech USA, INC. | $57.57 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Alexion Pharmaceuticals, INC. | $55.54 | 2022-2024 | Ultomiris |
| Inspire Medical Systems, INC. | $54.32 | 2024-2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $52.82 | 2023 | Quviviq |
| Alnylam Pharmaceuticals INC. | $49.95 | 2023-2024 | Onpattro |
| Sunovion Pharmaceuticals INC. | $49.67 | 2022 | |
| Grifols USA, LLC | $42.96 | 2025 | Gamunex-C |
| Biohaven Pharmaceutical Holding Company LTD. | $40.96 | 2022 | |
| Amneal Pharmaceuticals LLC | $38.30 | 2024 | Rytary, Ongentys |
| E.R. Squibb & Sons, L.L.C. | $33.96 | 2024 | Zeposia |
| Livanova USA, INC. | $28.44 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Allergan, INC. | $25.15 | 2022 | |
| Avion Pharmaceuticals | $24.75 | 2022 | |
| Amgen INC. | $23.12 | 2023 | Aimovig |
| Glaxosmithkline, LLC. | $16.41 | 2023 | Trelegy Ellipta |
| Kyowa Kirin, INC. | $16.31 | 2022 | |
| Nevro Corp. | $14.29 | 2023 | Senza |
| Sumitomo Pharma America, INC. | $13.81 | 2024 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.